TargetVasopressin V1a receptor(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research And Development
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:In vitro inhibitory concentration against [3H]-AVP binding to cloned human vasopressin V1a receptorMore data for this Ligand-Target Pair